NOSO-502, Bacterial Translation Inhibitor

NOSO-502 is an inhibitor of bacterial translation. NOSO-502 exhibits inhibitory activity against Enterobacteriaceae. NOSO-502 has good safety and antibacterial properties. - Mechanism of Action & Protocol.

Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species

Recent Updates on Bacterial Secondary Metabolites to Overcome Antibiotic Resistance in Gram-Negative Superbugs: Encouragement or Discontinuation?

In vitro and In vivo characterization of NOSO-502, a novel inhibitor of bacterial translation

Worm-associated bacteria are an untapped source of antibiotics

Nosopharm

Recent Updates on Bacterial Secondary Metabolites to Overcome Antibiotic Resistance in Gram-Negative Superbugs: Encouragement or Discontinuation?

Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses

A new antibiotic to fight antibiotic-resistant bacteria

In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation

The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific. - Abstract - Europe PMC